Abstract
Euphorbia jolkinii dominates the subalpine meadows in Shangri-La (Southwest China) owing to its potent allelopathic effects. However, the effects underlying its allelopathy require further characterization at the physiological and molecular levels. In this study, the physiological, biochemical, and metabolic mechanisms underlying E. jolkinii allelopathy were investigated using Arundinella hookeri as a receptor plant. The treatment of A. hookeri seedlings with E. jolkinii aqueous extract (EJAE) disrupted their growth by inhibiting photosynthesis, disrupting oxidation systems, and increasing soluble sugar accumulation and chlorophyll synthesis. Collectively, this causes severe impairment accompanied by abnormal photosynthesis and reduced biomass accumulation. Moreover, EJAE treatment suppressed gibberellin, indoleacetic acid, zeatin, salicylic acid, and jasmonic acid levels while promoting abscisic acid accumulation. Further metabolomic analyses identified numerous differentially abundant metabolites primarily enriched in the α-linolenic, phenylpropanoid, and flavonoid biosynthesis pathways in EJAE-treated A. hookeri seedlings. This study demonstrated that E. jolkinii exhibits potent and comprehensive allelopathic effects on receptor plants, including a significant disruption of endogenous hormone synthesis, the inhibition of photosynthesis, an impairment of membrane and oxidation systems, and changes in crucial metabolic processes associated with α-linolenic, phenylpropanoid, and flavonoid biosynthesis. Thus, our study provides a solid theoretical foundation for understanding the regulatory mechanisms underlying E. jolkinii allelopathy.